INTERNATIONAL PATENT: SHANGHAI JIAO TONG UNIVERSITY, 上海交通大学, SHANGHAI CHEST HOSPITAL, 上海市胸科医院 FILES APPLICATION FOR "USE OF PTPRT AS BIOMARKER AND TARGET FOR PREDICTING EFFICACY OF IMMUNE CHECKPOINT THERAPY IN LUNG CANCER"

Posted On: 2025-06-09

GENEVA, June 9 -- SHANGHAI JIAO TONG UNIVERSITY (No.800 Dongchuan RoadMinhang District, Shanghai 200240), 上海交通大学 (中国上海市闵行区东川路800号), SHANGHAI CHEST HOSPITAL (No.241 West Huaihai RoadXuhui District, Shanghai 200030), 上海市胸科医院 (中国上海市徐汇区淮海西路241号) filed a patent application (PCT/CN2024/135966) for "USE OF PTPRT AS BIOMARKER AND TARGET FOR PREDICTING EFFICACY OF IMMUNE CHECKPOINT THERAPY IN LUNG CANCER" on Nov 29, 2024. With publication no. WO/2025/113697, the details related to the pat...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI JIAO TONG UNIVERSITY, 上海交通大学, SHANGHAI CHEST HOSPITAL, 上海市胸科医院 FILES APPLICATION FOR "USE OF PTPRT AS BIOMARKER AND TARGET FOR PREDICTING EFFICACY OF IMMUNE CHECKPOINT THERAPY IN LUNG CANCER"